To answer this question, we assessed viral plaque formation in HCMV-infected HFFs (MOI 0.1) treated for 1 h prior to infection with increasing concentrations of Cl-amidine (Cl-A) (25–200 μM), a cell-permeable pan-PAD inhibitor27. The gene discussed is PADI4; the disease is infection.